Spectrum Pharmaceuticals reported $28.49M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Actinium Pharmaceuticals ATNM:US USD 5K 16K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Amgen AMGN:US USD 38.94B 241M
Astellas Pharma 4503:JP JPY 329.15B 41.15B
AstraZeneca AZN:LN USD 29.23B 67M
Bayer BAYN:GR EUR 41.65B 3.14B
Biogen BIIB:US USD 6.28B 1.8M
Bristol Myers Squibb BMY:US USD 39.32B 222M
Coherus Biosciences CHRS:US USD 473.67M 3.17M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
GlaxoSmithKline GSK:LN GBP 20.99B 1.13B
Intercept Pharmaceuticals ICPT:US USD 332.67M 365K
Karyopharm Therapeutics KPTI:US USD 302.82M 69K
Novartis NOVN:VX USD 27.91B 530M
Puma Biotechnology PBYI:US USD 98.31M 313K
Roche Holding ROG:VX 25.35B 2.4B
Takeda 4502:JP JPY 4.29T 449.74B
Teva Pharmaceutical TEVA:IT USD 21.21B 54M
Tg Therapeutics TGTX:US USD 71.13M 1.1M